IRadimed Ownership | Who Owns IRadimed?

Overview RevenueFinancials Chart Transcripts

IRadimed Ownership Summary

IRadimed is owned by 47.38% institutional investors, 36.78% insiders, and 15.84% retail investors. Blackrock funding, inc. /de is the largest institutional shareholder, holding 7.87% of IRMD shares. Vanguard US Total Market Shares ETF is the top mutual fund, with 2.05% of its assets in IRadimed shares.

IRMD Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	IRadimed	47.38%	36.78%	15.84%
Sector	Healthcare Stocks	232.01%	10.74%	-142.75%
Industry	Medical Device Stocks	37.54%	10.61%	51.85%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Blackrock funding, inc. /de	1.00M	7.87%	$97.47M
Blackrock	818.34K	6.46%	$35.96M
Nine ten capital management	771.38K	6.07%	$54.89M
Vanguard group	560.05K	4.40%	$54.48M
Renaissance	456.41K	3.59%	$44.40M
Copeland capital management	412.55K	3.24%	$40.13M
Bares capital management	283.60K	2.24%	$12.46M
Geode capital management	261.96K	2.06%	$25.49M
Dimensional fund advisors lp	217.13K	1.71%	$21.12M
Goldman sachs group	205.23K	1.61%	$19.96M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Nine ten capital management	771.38K	14.15%	$54.89M
Shaker investments llc/oh	62.24K	2.52%	$6.06M
Bridge city capital	70.85K	2.03%	$6.89M
Ballast asset management, lp	36.24K	1.67%	$3.53M
Albert d mason	17.02K	1.09%	$1.66M
Copeland capital management	412.55K	0.90%	$40.13M
Ranger investment management	111.47K	0.74%	$10.84M
Bares capital management	283.60K	0.60%	$12.46M
Eam investors	55.11K	0.60%	$5.36M
Isthmus partners	50.61K	0.55%	$4.92M

Top Buyers

Holder	Shares	% Assets	Change
Blackrock	818.34K	0.00%	159.59K
Goldman sachs group	205.23K	0.00%	55.43K
Eam investors	55.11K	0.60%	55.11K
T. rowe price investment management	50.10K	0.00%	50.10K
Sei investments	63.40K	0.01%	39.37K

Top Sellers

Holder	Shares	% Assets	Change
Rk capital management	-	-	-170.08K
Soleus capital management	-	-	-102.07K
Nine ten capital management	771.38K	14.15%	-100.62K
Hillsdale investment management	-	-	-97.40K
Roubaix capital	-	-	-71.50K

New Positions

Holder	Shares	% Assets	Change	Value
Eam investors	55.11K	0.60%	55.11K	$5.36M
T. rowe price investment management	50.10K	0.00%	50.10K	$3.57M
Punch & associates investment management	17.00K	0.07%	17.00K	$1.21M
Norges bank	16.50K	0.00%	16.50K	$725.01K
Rfg advisory	16.38K	0.03%	16.38K	$1.59M

Sold Out

Holder	Change
Tortoise investment management	-1.00
Nelson, van denburg & campbell wealth management group	-1.00
Newedge advisors	-3.00
Lindbrook capital	-4.00
Coldstream capital management	-8.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Dec 31, 2025	170	-8.11%	6,026,600	-12.82%	47	1.60%	87	-5.43%	58	-10.77%
Sep 30, 2025	181	16.77%	6,874,752	1.47%	54	1.90%	90	23.29%	64	30.61%
Jun 30, 2025	157	-5.99%	6,780,582	-2.59%	53	1.78%	72	-19.10%	51	2.00%
Mar 31, 2025	164	-1.80%	6,939,915	-0.10%	54	1.82%	88	-13.73%	48	23.08%
Dec 31, 2024	153	6.99%	6,650,148	-1.42%	52	1.85%	90	5.88%	38	5.56%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Vanguard US Total Market Shares ETF	260.30K	2.05%	-
Vanguard Total Stock Mkt Idx Inv	259.57K	2.04%	-
BBH Partner Fund Small Cap Equity	209.28K	1.65%	-40.72K
iShares Russell 2000 ETF	197.13K	1.55%	60.46K
Ranger Micro Cap	111.47K	0.88%	-8.15K
JNL Multi-Manager Small Cap Growth A	96.80K	0.76%	96.80K
Acuitas US Microcap Strategy	87.37K	0.69%	1.99K
Vanguard Institutional Extnd Mkt Idx Tr	86.89K	0.68%	-121.00
KAR Small-Mid Cap Growth	83.94K	0.66%	-462.00
T. Rowe Price Small-Cap Value	82.46K	0.65%	-3.54K

Recent Insider Transactions

Date	Name	Role	Activity	Value
Mar 10, 2026	Susi Roger E.	CEO, PRESIDENT, CHAIRMAN	Sell	$250.28K
Mar 09, 2026	Susi Roger E.	CEO, PRESIDENT, CHAIRMAN	Sell	$500.20K
Mar 06, 2026	Susi Roger E.	CEO, PRESIDENT, CHAIRMAN	Sell	$618.98K
Mar 06, 2026	Susi Roger E.	CEO, PRESIDENT, CHAIRMAN	Sell	$118.94K
Feb 13, 2026	ALLEN MONTY K	-	Sell	$100.26K

Insider Transactions Trends

Date	Buy	Sell
2026 Q1	-	17
2025 Q4	-	48
2025 Q3	-	4
2025 Q2	-	-
2024 Q4	-	2

IRMD Ownership FAQ

Who Owns IRadimed?

IRadimed shareholders are primarily institutional investors at 47.38%, followed by 36.78% insiders and 15.84% retail investors. The average institutional ownership in IRadimed's industry, Medical Device Stocks, is 37.54%, which IRadimed exceeds.

Who owns the most shares of IRadimed?

IRadimed’s largest shareholders are Blackrock funding, inc. /de (1M shares, 7.87%), Blackrock (818.34K shares, 6.46%), and Nine ten capital management (771.38K shares, 6.07%). Together, they hold 20.40% of IRadimed’s total shares outstanding.

Does Blackrock own IRadimed?

Yes, BlackRock owns 6.46% of IRadimed, totaling 818.34K shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 35.96M$. In the last quarter, BlackRock increased its holdings by 159.59K shares, a 24.23% change.

Who is IRadimed’s biggest shareholder by percentage of total assets invested?

Nine ten capital management is IRadimed’s biggest shareholder by percentage of total assets invested, with 14.15% of its assets in 771.38K IRadimed shares, valued at 54.89M$.

Who is the top mutual fund holder of IRadimed shares?

Vanguard US Total Market Shares ETF is the top mutual fund holder of IRadimed shares, with 2.05% of its total shares outstanding invested in 260.3K IRadimed shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools